SG165594G - 1-[3-(dimethylamino)propyl]-1-phenylphthalenes for the treatment of cerebrovascular disorders - Google Patents

1-[3-(dimethylamino)propyl]-1-phenylphthalenes for the treatment of cerebrovascular disorders

Info

Publication number
SG165594G
SG165594G SG165594A SG165594A SG165594G SG 165594 G SG165594 G SG 165594G SG 165594 A SG165594 A SG 165594A SG 165594 A SG165594 A SG 165594A SG 165594 G SG165594 G SG 165594G
Authority
SG
Singapore
Prior art keywords
dimethylamino
propyl
treatment
cerebrovascular disorders
phenylphthalenes
Prior art date
Application number
SG165594A
Other languages
English (en)
Inventor
Yoshiaki Tanaka
Naomi Kobayashi
Tadashi Kurimoto
Yugo Ikeda
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26066379&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG165594(G) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to DK213290A priority Critical patent/DK213290D0/da
Priority to IL9896891A priority patent/IL98968A/en
Priority to IE268291A priority patent/IE72160B1/en
Priority to ZA916187A priority patent/ZA916187B/xx
Priority to AT91610063T priority patent/ATE112166T1/de
Priority to NZ239437A priority patent/NZ239437A/en
Priority to DK91610063.9T priority patent/DK0474580T3/da
Priority to DE69104314T priority patent/DE69104314T2/de
Priority to CA002049368A priority patent/CA2049368C/en
Priority to EP91610063A priority patent/EP0474580B1/en
Priority to KR1019910014255A priority patent/KR970002246B1/ko
Priority to AU82594/91A priority patent/AU644204B2/en
Priority to JP3224192A priority patent/JPH085787B2/ja
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Priority to SG165594A priority patent/SG165594G/en
Priority to HK21595A priority patent/HK21595A/xx
Publication of SG165594G publication Critical patent/SG165594G/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG165594A 1990-09-06 1994-11-16 1-[3-(dimethylamino)propyl]-1-phenylphthalenes for the treatment of cerebrovascular disorders SG165594G (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
DK213290A DK213290D0 (da) 1990-09-06 1990-09-06 Treatment of cerebrovascular disorders
IL9896891A IL98968A (en) 1990-09-06 1991-07-25 A mixture of pharmaceuticals with a history of phenylphthalene for the treatment of cirrhoscular disorders
IE268291A IE72160B1 (en) 1990-09-06 1991-07-30 Use of 1-[3-(Dimethylamino)Propyl]-1-phenylphthalenes for the treatment of cerebrovascular disorders
ZA916187A ZA916187B (en) 1990-09-06 1991-08-06 Treatment of cerebrovascular disorders
EP91610063A EP0474580B1 (en) 1990-09-06 1991-08-16 Use of 1-[3-(dimethylamino)propyl]-1-phenylphthalenes for the treatment of cerebrovascular disorders
NZ239437A NZ239437A (en) 1990-09-06 1991-08-16 Use of 1-[3-(dimethylamino)propyl]-1-phenylphthalanes to treat dementia and cerebrovasular disorders and for inhibiting platelet aggregation
DK91610063.9T DK0474580T3 (da) 1990-09-06 1991-08-16 Anvendelse af 1-(3-dimethylamino)propyl)-1-phenylphthalener til behandling af cerebrovaskulære sygdomme
AT91610063T ATE112166T1 (de) 1990-09-06 1991-08-16 Verwendung von 1-(3-(dimethylamino)propyl>-1- phenylphthalenen zur behandlung zerebrovaskulärer störungen.
DE69104314T DE69104314T2 (de) 1990-09-06 1991-08-16 Verwendung von 1-[3-(Dimethylamino)propyl]-1-phenylphthalenen zur Behandlung zerebrovaskulärer Störungen.
CA002049368A CA2049368C (en) 1990-09-06 1991-08-16 Treatment of cerebro-vascular disorders
KR1019910014255A KR970002246B1 (ko) 1990-09-06 1991-08-19 뇌혈관 장해 치료용 약제조성물
AU82594/91A AU644204B2 (en) 1990-09-06 1991-08-20 Treatment of cerebrovascular disorders
JP3224192A JPH085787B2 (ja) 1990-09-06 1991-09-04 痴呆及び脳血管障害予防・治療剤並びに血小板凝集抑制剤
SG165594A SG165594G (en) 1990-09-06 1994-11-16 1-[3-(dimethylamino)propyl]-1-phenylphthalenes for the treatment of cerebrovascular disorders
HK21595A HK21595A (en) 1990-09-06 1995-02-16 Use of 1-(3-dimethyl-amino)propyl)-1-phenylphthalenes for the treatment of cerebrovascular disorders

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK213290A DK213290D0 (da) 1990-09-06 1990-09-06 Treatment of cerebrovascular disorders
SG165594A SG165594G (en) 1990-09-06 1994-11-16 1-[3-(dimethylamino)propyl]-1-phenylphthalenes for the treatment of cerebrovascular disorders

Publications (1)

Publication Number Publication Date
SG165594G true SG165594G (en) 1995-05-12

Family

ID=26066379

Family Applications (1)

Application Number Title Priority Date Filing Date
SG165594A SG165594G (en) 1990-09-06 1994-11-16 1-[3-(dimethylamino)propyl]-1-phenylphthalenes for the treatment of cerebrovascular disorders

Country Status (14)

Country Link
EP (1) EP0474580B1 (ko)
JP (1) JPH085787B2 (ko)
KR (1) KR970002246B1 (ko)
AT (1) ATE112166T1 (ko)
AU (1) AU644204B2 (ko)
CA (1) CA2049368C (ko)
DE (1) DE69104314T2 (ko)
DK (2) DK213290D0 (ko)
HK (1) HK21595A (ko)
IE (1) IE72160B1 (ko)
IL (1) IL98968A (ko)
NZ (1) NZ239437A (ko)
SG (1) SG165594G (ko)
ZA (1) ZA916187B (ko)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69801764T2 (de) * 1997-07-08 2002-07-04 Lundbeck & Co As H Verfahren zur herstellung von citalopram
JP4674339B2 (ja) * 1998-08-07 2011-04-20 三菱化学株式会社 脳損傷の予防・治療剤
PL199423B1 (pl) * 1998-10-20 2008-09-30 Lundbeck & Co As H Sposób wytwarzania citalopramu
JP2002533450A (ja) 1998-12-23 2002-10-08 ハー・ルンドベック・アクチエゼルスカベット ５−シアノフタリドの製造方法
EA004033B1 (ru) 1999-04-14 2003-12-25 Х.Лундбекк А/С Способ получения циталопрама
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
GB2357762B (en) 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
BG64901B1 (bg) * 2000-05-29 2006-08-31 H. Lundbeck A/S Метод за получаване на циталопрам
FI20011622A (fi) 2000-08-18 2002-02-19 Lundbeck & Co As H Menetelmä sitalopraamin valmistamiseksi
TR200201166T1 (tr) * 2000-12-22 2002-10-21 H.Lundbecks A/S Saf sitalopram hazırlanması için yöntem
BG65515B1 (bg) * 2002-07-26 2008-10-31 H. Lundbeck A/S Метод за получаване на 5-цианофталид
PL1691811T3 (pl) 2003-12-11 2014-12-31 Sunovion Pharmaceuticals Inc Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
TW200812993A (en) * 2006-05-02 2008-03-16 Lundbeck & Co As H New uses of escitalopram
DE102007051090A1 (de) 2007-06-28 2009-01-08 Charité - Universitätsmedizin Berlin SSRI zur Behandlung neuronaler Krankheiten
EP2008653A1 (de) 2007-06-28 2008-12-31 Charité-Universitätsmedizin Berlin Serotonerge Verbindungen zur Behandlung neuronaler Krankheiten
CN104005415B (zh) * 2014-02-18 2015-12-02 中铁十六局集团北京轨道交通工程建设有限公司 微风化花岗岩中地下连续墙的高效成槽施工方法
CN106871753B (zh) * 2017-01-04 2018-10-16 中铁隧道集团有限公司 一种用于提高水平岩层隧道成型的装药方法

Also Published As

Publication number Publication date
IE72160B1 (en) 1997-03-26
JPH085787B2 (ja) 1996-01-24
IE912682A1 (en) 1992-03-11
NZ239437A (en) 1997-02-24
AU8259491A (en) 1992-03-12
KR970002246B1 (ko) 1997-02-26
KR920005983A (ko) 1992-04-27
HK21595A (en) 1995-02-24
JPH04244024A (ja) 1992-09-01
IL98968A0 (en) 1992-07-15
EP0474580A2 (en) 1992-03-11
EP0474580B1 (en) 1994-09-28
DE69104314T2 (de) 1995-02-16
CA2049368C (en) 2001-10-23
DK213290D0 (da) 1990-09-06
ZA916187B (en) 1992-04-29
IL98968A (en) 1996-06-18
EP0474580A3 (en) 1992-06-03
DK0474580T3 (da) 1995-04-03
ATE112166T1 (de) 1994-10-15
DE69104314D1 (de) 1994-11-03
AU644204B2 (en) 1993-12-02
CA2049368A1 (en) 1992-03-07

Similar Documents

Publication Publication Date Title
SG165594G (en) 1-[3-(dimethylamino)propyl]-1-phenylphthalenes for the treatment of cerebrovascular disorders
GB2256196B (en) Heterocyclic derivatives
GR3018557T3 (en) Hydantoin derivatives.
FI941378A0 (fi) Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus
GR3030798T3 (en) 2-(Piperidin-4-yl, pyridin-4-yl and tetrahydropyridin-4-yl)benzofuran-7-ol and carbamate derivatives, their preparation and their use as acetylcholinesterase inhibitors.
ZA89389B (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
FI935800A0 (fi) Antidepressiva och mot Parkisons sjukdom verksamma foereningar
DE69018726D1 (de) Cumarinderivate, ihre Herstellung und ihre Verwendung zur Behandlung von zerebrovaskulären Störungen.
IL93161A0 (en) 3-phenyl-5,6-dihydrobenz(c)acridine-7-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
EP0285284A3 (en) N-phenethylaminoalkyl-benzamide anti-arrhythmia agents
FR2666741B1 (fr) Composition therapeutique pour inhiber l'agregation plaquettaire.
JPS579780A (en) Carbostyril derivative
ES8602723A1 (es) Un procedimiento para la preparacion de nuevas n-bencil-propilaminas sustituidas.
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
ZA88639B (en) Substituted 3-phenyl-7h-thiazolo(3,2-b)(1,2,4)triazin-7-ones,a process for the preparation thereof,medicaments containing same and the use thereof,and also some intermediates formed in the preparation of the compounds mentioned
DE69327077T2 (de) Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen
RO95572A2 (ro) Procedeu pentru prepararea unor derivati de 1,3-oxazolidin-2-ona